Guo Feng, Founder of GenZee Bio, Confirmed to Speak at the 3rd International Medical Device Innovation Summit
In the fields of in vitro diagnostics, high-value consumables, and rehabilitation equipment, how can the correct development path be identified through upstream-downstream supply chain collaboration, upgrading of the technological and industrial foundation, and coordinated integration of key industrial development factors?June 22, 2021，2021 The 3rd International Summit on Medical Device Innovationscheduled toNanjing · Gaochunheld. This event will focus on“Intelligent Manufacturing as the Foundation, Collaborative Innovation”Centered on the theme, this offline medical device industry summit will bring together the most active domestic and international medical device innovators, listed companies, financial institutions, and healthcare providers through formats such as the Medical Device Vitality Rankings, closed-door government-enterprise meetings, overseas live connections, keynote speeches, and roundtable discussions.
This event is hosted by the Nanjing New Medicine and Life Health Industry Chain Task Force and the People’s Government of Gaochun District, Nanjing; organized by the Office of the Innovation Committee of the CPC Gaochun District Committee and VCBeat; and co-organized by Jiangsu Gaochun Economic Development Zone and Jiangsu Gaochun High-Tech Industrial Development Zone.
Guo Feng, Founder of Zhenzhun BioConfirmation of Attendance at the 3rd International Summit on Medical Device Innovation, and will publish related insights.
Click the image to register
Guo Feng, Founder of Zhenzhun Biology
Guo Feng holds a master’s degree from Shanghai Jiao Tong University. After graduation, he worked for many years at Fortune 500 companies such as Agilent Technologies and Medtronic, accumulating extensive practical experience in product R&D, project management, marketing, and corporate operations. In 2016, he founded Zhenzhun Biotechnology, leading the team to successfully launch chip-based digital PCR products at a world-leading level, thereby establishing himself as an expert in this field. The company was selected as one of the “Top 50 Most Investable Startups in Shanghai” in 2018, received investment from Anlong Fund in 2019, and was recognized as one of the “VCBeat 100 Future Healthcare Companies with Annual Potential” in 2021.
Zhenzhun Bio is dedicated to the research, development, and manufacturing of high-end instruments in the field of in vitro diagnostics, and has launched chip-based digital PCR.Guo Feng stated that the research, development, and manufacturing of digital PCR instruments constitute a high-end sector that integrates advanced technologies and specialized expertise in micro-nano fabrication processes, the manufacturing supply chain, software algorithms, and application development. In this field, domestic technologies have become highly mature and are at the global forefront; consequently, the performance of Chinese-made digital PCR instruments has reached or surpassed that of foreign products.The Future Digital PCR Market Will See Long-Term Coexistence of Domestic and Imported BrandsAs long as domestic enterprises offer affordable prices and efficient services while maintaining superior product performance, they will surely prevail in the competition by creating high-quality, accessible digital PCR instruments.
At the summit, we have specially invitedNobel Laureate in Physiology or Medicine, Academician of the Chinese Academy of Sciences and the Chinese Academy of EngineeringDistinguished experts will share cutting-edge domestic and international technologies and frontier medical advancements, focusing on medical development amidst technological transformation, and redefining the evolutionary logic of technology and innovative thinking in the industry.
Senior executives from leading medical device companies, outstanding innovative entrepreneurs, seasoned directors of innovation departments, and experienced investors will focus on ““Growth Curve of the IVD Industry in the Post-Pandemic Era,” “High-Value Consumables Amid Domestic Substitution and Volume-Based Procurement,” and “Innovation in Rehabilitation Products and Application Scenarios in an Aging Society”Conduct in-depth discussions along three main lines.
Currently, the 2014 Nobel Prize laureate in Physiology or Medicine,Edvard MoserConfirmed participation in this event, and will deliver a presentation on"How the Brain Works: A Spatial Systems Approach to Decoding Computation in the Brain"Related Sharing.Academician of the Chinese Academy of Sciences and neurosurgery expert Zhao Jizong; Academician of the Chinese Academy of Engineering Zhang ZhiyuanAll confirmed their attendance and delivered relevant presentations.
The 2021 List of Innovative Vitality in Medical Devices is part of the regular series of the Top 100 Future Healthcare Companies. VCBeat, with industrial research as its foundation, focuses on innovative development, technological transformation, and policy updates in the medical device sector, while identifying high-growth innovative medical device companies fromIn Vitro Diagnostics (Digital PCR)、High-Value Consumables (Cardiovascular Intervention)、Rehabilitation Equipment (Rehabilitation Robotics)The 2021 Innovative and Vital Medical Device Enterprises were selected based on the rankings across three fundamental dimensions and the “Black Tech” in Medical Devices ranking.
The 2021 Medical Device Innovation Vitality List will be announced at the 3rd International Summit on Medical Device Innovation in 2021., and will be disseminated and promoted through VCBeat’s online media matrix.
(Listed in the order of guest speakers)
Edward Mosol, the 2014 Nobel Prize in Physiology or Medicine
Zhao Jizong, Academician of the Chinese Academy of Sciences, neurosurgeon
Zhang Zhiyuan, Academician of the Chinese Academy of Engineering
Deng Jianmin, Senior Vice President of BD Worldwide and General Manager of Greater China
Kang Keran, Senior Vice President of Wondfo Biotech
Shen Qin, Partner at Shengyu Investment
Yang Bin, Director of the Smart Health Center, Institute for Precision Medicine, Tsinghua University
Jin Ge, Founder and Chairman of Rendong Medicine
Guo Feng, Founder of Zhenzhun Bio
Peng Yifei, General Manager of Tigermed Jietong
Jin Lei, CEO of BaiRen Medical
Wang Jinhe, Vice President of Johnson & Johnson MedTech
Zhang Bing, Director of Market Access and Government Affairs at Double Medical
Yang He, CEO of Weimai Medical
Geng Yan, Chairman of Yizheng Medical
Wang Jun, Partner at Puhua Capital
Yu Jurong, Partner at Heju Yinuo
Zhu Zhiyang, Chairman of Suruiqi Medical
Xu Junhua, Founder of Aomei Health
Xu Changjun, CEO of Julu Medical
Yang Zhihao, Vice President of Fourier Intelligence
Zhang Jiyu, COO of Chengtian Technology
More guests to be confirmed...
You Are Only One Ticket Away from Industry Leaders
Time:Tuesday, June 22, 2021
Location:China · Nanjing
Conference Official Website:https://vcbeat.top/Forum/summitIndex3
Click the image above or scan the QR code to register for free